secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2024-09-26T23:59:59+00:00
Accession:  0001326190-24-000042
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune Announces Stockholder Voting Results from 2024 Annual Meeting
-----------------------------------------------------------------------

- All seven director nominees were elected, with Mitchel Sayare receiving 21,231,279 votes for and 660,730 withheld, and broker non-votes of 21,784,295.
- Ratification of Ernst & Young as auditor passed with 43,204,496 votes for, 315,411 against.
- Advisory say-on-pay proposal passed with 13,663,909 votes for, 7,992,177 against, and 21,784,295 broker non-votes.
- Proposal to authorize adjournment for proxy solicitation passed with 26,771,350 votes for, 16,249,120 against.
- Total shares voted: 43,676,304 out of 71,070,951 outstanding, representing 61.5% quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619024000042/0001326190-24-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619024000042/alt-20240926x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-24-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer